BioCentury
ARTICLE | Company News

Alkermes, Elan deal

March 12, 2012 7:00 AM UTC

Elan divested a 16% stake, or about $346.5 million, in Alkermes through the sale of 21 million Alkermes shares at $16.50 in a registered offering underwritten by Citigroup; Jefferies; Morgan Stanley; ...